- Home
- MLTX
MLTX
MoonLake Immunotherapeutics
as 11-15-2024 4:00pm EST
| Founded: | 2021 | Country: | Switzerland |
| Employees: | N/A | City: | ZUG |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $77.43 | AVG Volume (30 days): | 234.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.30 | EPS Growth: | N/A |
| 52 Week Low/High: | $37.55 - $64.98 | Next Earning Date: | 11-07-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of MoonLake Immunotherapeutics (MLTX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| BVF PARTNERS L P/IL | MLTX | Director10% Owner | Oct 4 '24 | Sell | $50.00 | 2,000,000 | $100,003,200.00 | 10,235,089 |
Latest MoonLake Immunotherapeutics News
MLTX Breaking Stock News: Dive into MLTX Ticker-Specific Updates for Smart Investing
GlobeNewswire
4 days ago
MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritis
MT Newswires
10 days ago
MoonLake Immunotherapeutics' Q3 Net Loss Widens
GlobeNewswire
10 days ago
MoonLake Immunotherapeutics Reports Third Quarter 2024 Financial Results and Provides a Business Update
Argus Research
a month ago
Daily – Vickers Top Buyers & Sellers for 10/09/2024
GuruFocus.com
a month ago
Biotechnology Value Fund L.P. Reduces Stake in MoonLake Immunotherapeutics
MT Newswires
a month ago
Moonlake Immunotherapeutics Insider Sold Shares Worth $9,186,120, According to a Recent SEC Filing
Insider Monkey
2 months ago
Is MoonLake Immunotherapeutics (MLTX) the Best Guru Stock To Buy Now?
Insider Monkey
2 months ago
MoonLake Immunotherapeutics (MLTX): Short Seller Sentiment is Bearish On This ADR Stock
Compare MLTX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MLTX MoonLake Immunotherapeutics - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.